VectivBio (VECT) Competitors $16.85 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock VECT vs. EWTX, CGON, CNTA, KYMR, BLTE, DNLI, ARQT, ARWR, TARS, and HRMYShould you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include Edgewise Therapeutics (EWTX), CG Oncology (CGON), Centessa Pharmaceuticals (CNTA), Kymera Therapeutics (KYMR), Belite Bio (BLTE), Denali Therapeutics (DNLI), Arcutis Biotherapeutics (ARQT), Arrowhead Pharmaceuticals (ARWR), Tarsus Pharmaceuticals (TARS), and Harmony Biosciences (HRMY). These companies are all part of the "pharmaceutical products" industry. VectivBio vs. Edgewise Therapeutics CG Oncology Centessa Pharmaceuticals Kymera Therapeutics Belite Bio Denali Therapeutics Arcutis Biotherapeutics Arrowhead Pharmaceuticals Tarsus Pharmaceuticals Harmony Biosciences VectivBio (NASDAQ:VECT) and Edgewise Therapeutics (NASDAQ:EWTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking. Is VECT or EWTX more profitable? VectivBio's return on equity of 0.00% beat Edgewise Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A Edgewise Therapeutics N/A -26.83%-25.67% Does the media favor VECT or EWTX? In the previous week, Edgewise Therapeutics had 8 more articles in the media than VectivBio. MarketBeat recorded 8 mentions for Edgewise Therapeutics and 0 mentions for VectivBio. Edgewise Therapeutics' average media sentiment score of 0.99 beat VectivBio's score of 0.00 indicating that Edgewise Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral Edgewise Therapeutics Positive Does the MarketBeat Community prefer VECT or EWTX? Edgewise Therapeutics received 26 more outperform votes than VectivBio when rated by MarketBeat users. Likewise, 73.47% of users gave Edgewise Therapeutics an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% Edgewise TherapeuticsOutperform Votes3673.47% Underperform Votes1326.53% Do analysts rate VECT or EWTX? Edgewise Therapeutics has a consensus price target of $45.38, suggesting a potential upside of 125.41%. Given Edgewise Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Edgewise Therapeutics is more favorable than VectivBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VectivBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Edgewise Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Which has more volatility & risk, VECT or EWTX? VectivBio has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, Edgewise Therapeutics has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Which has stronger valuation and earnings, VECT or EWTX? VectivBio has higher revenue and earnings than Edgewise Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34M20.97-$93.74MN/AN/AEdgewise TherapeuticsN/AN/A-$100.16M-$1.45-13.88 SummaryEdgewise Therapeutics beats VectivBio on 8 of the 12 factors compared between the two stocks. Remove Ads Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VECT vs. The Competition Export to ExcelMetricVectivBioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$573.24M$2.93B$5.55B$7.86BDividend YieldN/A1.55%5.35%4.05%P/E RatioN/A30.1323.4918.67Price / Sales20.97396.66368.1387.32Price / CashN/A168.6838.1634.64Price / BookN/A3.656.634.09Net Income-$93.74M-$71.95M$3.20B$246.93M7 Day PerformanceN/A-11.60%-6.38%-3.79%1 Month PerformanceN/A-18.83%-1.52%-6.75%1 Year PerformanceN/A-32.07%7.30%-1.88% VectivBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeEWTXEdgewise Therapeutics1.9371 of 5 stars$22.80-2.4%$45.38+99.0%+20.6%$2.17BN/A-15.2060CGONCG Oncology1.1495 of 5 stars$27.54-3.5%$63.88+131.9%-44.2%$2.09B$684,000.000.0061Earnings ReportAnalyst ForecastNews CoverageCNTACentessa Pharmaceuticals2.9405 of 5 stars$15.81-4.9%$26.00+64.5%+27.3%$2.08B$6.85M-10.33200Analyst ForecastAnalyst RevisionNews CoverageKYMRKymera Therapeutics1.3339 of 5 stars$31.82-5.6%$56.36+77.1%-31.9%$2.07B$47.07M-13.60170Positive NewsBLTEBelite Bio2.1867 of 5 stars$64.50-3.7%$96.33+49.4%+72.6%$2.05BN/A-58.1110DNLIDenali Therapeutics4.3815 of 5 stars$14.12-4.3%$37.20+163.5%-33.7%$2.05B$330.53M-5.12430Positive NewsARQTArcutis Biotherapeutics3.446 of 5 stars$17.11-1.0%$18.80+9.9%+57.8%$2.03B$196.54M-9.56150Short Interest ↓ARWRArrowhead Pharmaceuticals3.4441 of 5 stars$14.73-5.0%$41.44+181.4%-55.5%$2.02B$2.50M-2.85400TARSTarsus Pharmaceuticals2.7039 of 5 stars$51.33-2.0%$63.67+24.0%+41.3%$1.97B$182.95M-13.4750HRMYHarmony Biosciences4.4705 of 5 stars$32.99-3.7%$53.33+61.7%-1.2%$1.89B$714.73M15.64200Positive News Remove Ads Related Companies and Tools Related Companies EWTX Alternatives CGON Alternatives CNTA Alternatives KYMR Alternatives BLTE Alternatives DNLI Alternatives ARQT Alternatives ARWR Alternatives TARS Alternatives HRMY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VECT) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VECT Stock Free VECT Stock Alerts